Trials / Completed
CompletedNCT03239067
Comparison Of Efficacy and Safety Between Ticagrelor and Clopidogrel In Chinese
Comparison of Short- and Long-term Efficacy and Safety Between Ticagrelor and Clopidogrel in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9,040 (actual)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, single-center study to assess the long- and short-term outcomes of ticagrelor vs clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention. Patients will undergo face-to-face interviews, phone calls, or/and chart reviews at 7 days, 1 month, 6 months and 12 months. When 4500 patients have completed the follow-up, an interim analysis will be performed.
Conditions
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2021-10-24
- Completion
- 2021-10-24
- First posted
- 2017-08-03
- Last updated
- 2021-11-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03239067. Inclusion in this directory is not an endorsement.